Improving Resilience Of Post-Pandemic Biopharma Supply Chains
Improving supply chain resilience is critical for biopharma. One lesson learned from the pandemic is the need for new models and approaches to managing supply chains. Download our white paper to learn more about how a value chain model mitigates risk, the four critical ingredients to supply chain resilience, and why preparations based on “the last war” aren’t enough.
Knowing when it’s time to raise funds, fortify a CMC initiative, hire a chief regulatory or commercial officer, or make virtually any other big money move in biopharma isn’t art, it’s science. Business progress, as in scientific progress, is a data-driven exercise.
Pharmaceutical companies should prioritize gaining control over the talent management process in order to build a robust candidate pipeline. Here are four effective strategies for recruiting, training, educating, and retaining workers.
The clinical trial ecosystem is complex, but making smart choices and enlisting effective help allows private practices to contribute to life-changing research.
Inside you will find more on:
- Krystal Biotech's Founders
- Novel Business Models
- Regulatory Topics
- Companies To Watch
View the digital edition.
CONTRIBUTE TO LIFE SCIENCE LEADER
Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.
|Connect With Life Science Leader:|